Sepio Capital, LP Cerus Corp Transaction History

Sepio Capital, LP

$981 Million
Q1 2024

A detailed history of Sepio Capital, LP transactions in Cerus Corp stock. As of the latest transaction made, Sepio Capital, LP holds 1,347,500 shares of CERS stock, worth $2.41 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,347,500

Previous 147,500 813.56%

Holding current value

$2.41 Million

Previous $318,000 700.63%

% of portfolio

0.26%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.66 - $2.42 $1.99 Million - $2.9 Million	1,200,000 Added 813.56%	1,347,500 $2.55 Million
Q4 2023 Feb 09, 2024	SELL	$1.25 - $2.35 $4.19 Million - $7.87 Million	-3,349,907 Reduced 95.78%	147,500 $318,000
Q3 2023 Nov 08, 2023	BUY	$1.5 - $3.07 $4.66 Million - $9.53 Million	3,104,062 Added 789.14%	3,497,407 $5.67 Million
Q2 2023 Aug 08, 2023	BUY	$1.79 - $2.9 $173,370 - $280,879	96,855 Added 32.67%	393,345 $967,000
Q1 2023 May 10, 2023	SELL	$2.65 - $3.81 $602,411 - $866,108	-227,325 Reduced 43.4%	296,490 $880,000

Q4 2022 Feb 03, 2023	BUY	$3.38 - $4.22 $813,312 - $1.02 Million	240,625 Added 84.97%	523,815 $1.91 Million
Q3 2022 Oct 28, 2022	SELL	$3.43 - $5.83 $814,710 - $1.38 Million	-237,525 Reduced 45.62%	283,190 $1.02 Million
Q2 2022 Jul 26, 2022	BUY	$4.41 - $5.69 $9,702 - $12,518	2,200 Added 0.42%	520,715 $1.5 Million
Q1 2022 May 09, 2022	BUY	$4.81 - $6.99 $1.07 Million - $1.56 Million	222,725 Added 75.3%	518,515 $1.54 Million
Q4 2021 Jan 25, 2022	SELL	$5.97 - $7.93 $16,119 - $21,411	-2,700 Reduced 0.9%	295,790 $2.01 Million
Q3 2021 Nov 03, 2021	BUY	$4.79 - $6.68 $12,933 - $18,036	2,700 Added 0.91%	298,490 $1.82 Million
Q2 2021 Jul 26, 2021	SELL	$5.35 - $6.35 $19,795 - $23,495	-3,700 Reduced 1.24%	295,790 $1.75 Million
Q1 2021 May 10, 2021	SELL	$5.68 - $7.87 $1.97 Million - $2.73 Million	-347,500 Reduced 53.71%	299,490 $1.8 Million
Q4 2020 Feb 10, 2021	BUY	$5.25 - $8.56 $822,517 - $1.34 Million	156,670 Added 31.95%	646,990 $4.48 Million
Q3 2020 Nov 12, 2020	BUY	$5.78 - $7.47 $49,939 - $64,540	8,640 Added 1.79%	490,320 $3.07 Million
Q2 2020 Aug 04, 2020	BUY	$4.5 - $7.02 $531,000 - $828,360	118,000 Added 32.45%	481,680 $3.18 Million
Q1 2020 Apr 29, 2020	BUY	$2.87 - $5.49 $387,929 - $742,066	135,167 Added 59.15%	363,680 $1.69 Million
Q4 2019 Feb 06, 2020	SELL	$3.84 - $4.86 $27,072 - $34,263	-7,050 Reduced 2.99%	228,513 $964,000
Q3 2019 Oct 25, 2019	SELL	$4.86 - $6.05 $7.12 Million - $8.86 Million	-1,464,470 Reduced 86.14%	235,563 $1.21 Million
Q1 2019 May 14, 2019	SELL	$5.16 - $6.85 $8.69 Million - $11.5 Million	-1,684,384 Reduced 49.77%	1,700,033 $10.6 Million
Q4 2018 Feb 13, 2019	BUY	$4.89 - $7.16 $16.5 Million - $24.2 Million	3,384,417 New	3,384,417 $16 Million

Others Institutions Holding CERS

# of Institutions

153

Shares Held

144M

Call Options Held

39.6K

Put Options Held

60.9K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.

Account